Literature DB >> 8386871

The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM.

E M Barnett1, S Perlman.   

Abstract

Several viruses, including mouse hepatitis virus strain JHM (MHV-JHM), enter the brain after intranasal inoculation and spread transneuronally to other parts of the central nervous system (CNS). Both the olfactory and trigeminal nerves innervate the nasal cavity and are potential portals of virus entry into the CNS. To evaluate the relative importance of each nerve for MHV infection, mice were infected under conditions that discriminated between trigeminal and olfactory nerve entry. When olfactory nerve entry was selectively eliminated by surgical removal of both olfactory bulbs or by chemical destruction of the olfactory epithelium, MHV-JHM spread into the CNS was completely prevented. On the other hand, direct inoculation into the olfactory bulb, which eliminates all entry via the trigeminal nerve, had no effect on the pattern of virus infection. Thus MHV-JHM enters the CNS via the olfactory nerve after intranasal inoculation while entry via the trigeminal nerve is an insignificant part of this process.

Entities:  

Mesh:

Year:  1993        PMID: 8386871     DOI: 10.1006/viro.1993.1248

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

Review 1.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

Review 2.  Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  J Neural Transm (Vienna)       Date:  2015-05-06       Impact factor: 3.575

3.  T cell engagement of cross-presenting microglia protects the brain from a nasal virus infection.

Authors:  E Ashley Moseman; Alexa C Blanchard; Debasis Nayak; Dorian B McGavern
Journal:  Sci Immunol       Date:  2020-06-05

4.  Gene transfer by viral vectors for gene therapy.

Authors:  Y Becker; G Darai
Journal:  J Mol Med (Berl)       Date:  1995-03       Impact factor: 4.599

5.  Murine Olfactory Bulb Interneurons Survive Infection with a Neurotropic Coronavirus.

Authors:  D Lori Wheeler; Jeremiah Athmer; David K Meyerholz; Stanley Perlman
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

6.  Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43.

Authors:  Mathieu Dubé; Alain Le Coupanec; Alan H M Wong; James M Rini; Marc Desforges; Pierre J Talbot
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

7.  Pharmacoimaging of Blood-Brain Barrier Permeable (FDG) and Impermeable (FLT) Substrates After Intranasal (IN) Administration.

Authors:  Laura L Boles Ponto; Susan Walsh; Jiangeng Huang; Christine Mundt; Katherine Thede-Reynolds; G Leonard Watkins; John Sunderland; Michael Acevedo; Maureen Donovan
Journal:  AAPS J       Date:  2017-12-07       Impact factor: 4.009

8.  Detection of mouse-adapted human influenza virus in the olfactory bulbs of mice within hours after intranasal infection.

Authors:  Jeannine A Majde; Stewart G Bohnet; Georgeann A Ellis; Lynn Churchill; Victor Leyva-Grado; Melissa Wu; Eva Szentirmai; Abdur Rehman; James M Krueger
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

9.  The olfactory nerve has a role in the body temperature and brain cytokine responses to influenza virus.

Authors:  Victor H Leyva-Grado; Lynn Churchill; Joseph Harding; James M Krueger
Journal:  Brain Behav Immun       Date:  2009-10-29       Impact factor: 7.217

10.  Microglia are required for protection against lethal coronavirus encephalitis in mice.

Authors:  D Lori Wheeler; Alan Sariol; David K Meyerholz; Stanley Perlman
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.